IMR Press / FBL / Volume 12 / Issue 11 / DOI: 10.2741/2380

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
DNA repair pathways and hereditary cancer susceptibility syndromes
Show Less
1 The Graduate Center for Toxicology, University of Kentucky College of Medicine, Lexington KY 40536, USA
2 The Markey Cancer Center,University of Kentucky College of Medicine, Lexington KY 40536, USA
3 Department of Pediatrics, University of Kentucky College of Medicine, Lexington KY 40536, USA
Academic Editor:Guo-Min Li
Front. Biosci. (Landmark Ed) 2007, 12(11), 4191–4207;
Published: 1 May 2007
(This article belongs to the Special Issue DNA repair genes and human diseases)

Every living organism is exposed to numerous genomic insults on a daily basis as a consequence of cellular metabolism and exposure to environmental agents capable of interacting with the genome (e.g. chemicals, toxins, pollutants, UV and ionizing radiation) (1). Maintenance of the integrity of the genome is paramount to the survival and propagation of a species and involves the continuous activity of a variety of DNA repair pathways. Inherited mutations in genes involved in DNA damage recognition and repair lead to disease by destabilization of the genome and increased mutagenesis. In fact, it is common for cancer cells to exhibit loss of genomic stability presumably as a result of clonally acquired mutations in DNA repair genes (2). Currently, roughly 150 DNA repair genes have been identified in humans (3) and a variety of familial cancer predisposition and/or premature aging syndromes are now linked to various loss-of-function mutations in these genes (4). Genetic interaction between DNA repair pathways and global cell differentiation pathways is supported by phenotypic similarities between inactivating mutations in a DNA repair, cell cycle arrest and apoptosis proteins. Though there is clearly some degree of functional redundancy between DNA repair pathways for correction of specific DNA lesions, the particular clinical characteristics of a repair defect can be predicted by the specific repair pathway affected (5). Patients with cancer predisposition syndromes often have multiple family members affected by cancer, develop cancer at an early age, and are at risk for developing multiple primary tumors over time (6, 7). Though patients with identifiable cancer predisposition syndromes are rare, defining their molecular defects has led to widespread applicability by uncovering relevant molecular pathways that are perturbed via somatic (non-inherited) mutations in the majority of sporadic cancers. In this review, we describe general molecular mechanisms of major forms of DNA repair and illustrate clinical consequences of deficiencies in these pathways. For more in depth detail, the reader is referred to several recent reviews and texts (2, 8-13).

DNA repair
Nucleotide Excision Repair
Base Excision Repair
Mismatch Repair
Recombinational Repair
MutYH-associated poluposis
Xerderma Pigmentosum
Hereditary Nonpolyposis Colorectal Cancer
Fanconi anemia
Back to top